Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study ; day:8 ; month:9 ; year:2020 ; pages:1-16
Infectious diseases and therapy ; (8.9.2020), 1-16
- Urheber
-
Atsukawa, Masanori
Tsubota, Akihito
Kondo, Chisa
Toyoda, Hidenori
Nakamuta, Makoto
Takaguchi, Koichi
Watanabe, Tsunamasa
Hiraoka, Atsushi
Uojima, Haruki
Ishikawa, Toru
Iwasa, Motoh
Tada, Toshifumi
Nozaki, Akito
Chuma, Makoto
Fukunishi, Shinya
Asai, Akira
Asano, Toru
Ogawa, Chikara
Abe, Hiroshi
Hotta, Naoki
Shima, Toshihide
Iio, Etsuko
Mikami, Shigeru
Tachi, Yoshihiko
Fujioka, Shinichi
Okubo, Hironao
Shimada, Noritomo
Tani, Joji
Hidaka, Isao
Moriya, Akio
Tsuji, Kunihiko
Akahane, Takehiro
Yamashita, Naoki
Okubo, Tomomi
Arai, Taeang
Morita, Kiyoshi
Kawata, Kazuhito
Tanaka, Yasuhito
Okanoue, Takeshi
Maeda, Shin
Kumada, Takashi
Iwakiri, Katsuhiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-020-00329-y
- URN
-
urn:nbn:de:101:1-2020102817595940828880
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Atsukawa, Masanori
- Tsubota, Akihito
- Kondo, Chisa
- Toyoda, Hidenori
- Nakamuta, Makoto
- Takaguchi, Koichi
- Watanabe, Tsunamasa
- Hiraoka, Atsushi
- Uojima, Haruki
- Ishikawa, Toru
- Iwasa, Motoh
- Tada, Toshifumi
- Nozaki, Akito
- Chuma, Makoto
- Fukunishi, Shinya
- Asai, Akira
- Asano, Toru
- Ogawa, Chikara
- Abe, Hiroshi
- Hotta, Naoki
- Shima, Toshihide
- Iio, Etsuko
- Mikami, Shigeru
- Tachi, Yoshihiko
- Fujioka, Shinichi
- Okubo, Hironao
- Shimada, Noritomo
- Tani, Joji
- Hidaka, Isao
- Moriya, Akio
- Tsuji, Kunihiko
- Akahane, Takehiro
- Yamashita, Naoki
- Okubo, Tomomi
- Arai, Taeang
- Morita, Kiyoshi
- Kawata, Kazuhito
- Tanaka, Yasuhito
- Okanoue, Takeshi
- Maeda, Shin
- Kumada, Takashi
- Iwakiri, Katsuhiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/Velpatasvir
Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
Systematically analysis of decompensated cirrhotic patients with spontaneous bacterial peritonitis to identify diagnostic and prognostic indexes
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
Cirrhotic cardiomyopathy
Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor
Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients
Efficacy of 8-week daclatasvir-sofosbuvir regimen in chronic hepatitis C: a systematic review and meta-analysis
A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/Velpatasvir
Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
Systematically analysis of decompensated cirrhotic patients with spontaneous bacterial peritonitis to identify diagnostic and prognostic indexes
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
Cirrhotic cardiomyopathy
Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor
Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients
Efficacy of 8-week daclatasvir-sofosbuvir regimen in chronic hepatitis C: a systematic review and meta-analysis
A Hepatitis C Virus-Associated Decompensated Cirrhotic Patient Who Showed the Disappearance of Hepatic Encephalopathy, Ascites, and Pleural Effusion by Antiviral Therapy with Sofosbuvir/Velpatasvir
Successful Treatment with Crushed Sofosbuvir/Velpatasvir of a Patient with Decompensated Cirrhosis C and Thrombocytopenia
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
Systematically analysis of decompensated cirrhotic patients with spontaneous bacterial peritonitis to identify diagnostic and prognostic indexes
Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report
Cirrhotic cardiomyopathy
Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor
Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
Real-World Effectiveness of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve, Compensated Cirrhotic HCV Patients